Exponent CEO exercises options, sells shares
Exponent Inc. reported that CEO Catherine Corrigan exercised non-qualified stock options for 2,379 shares of common stock at $29.05 per share and on the same date sold 1,737 shares at $62.7776 per share to cover the option exercise price and taxes.
Rhea-AI Filing Summary
Exponent Inc. reported that CEO Catherine Corrigan exercised non-qualified stock options for 2,379 shares of common stock at $29.05 per share and on the same date sold 1,737 shares at $62.7776 per share to cover the option exercise price and taxes. After these trades, she directly held 115,771 common shares, and the transactions were effected under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) F3, F2 | 2,379 | -- | -- |
| Exercise | Common Stock | 2,379 | $29.05 | $69K |
| Sale | Common Stock F1 | 1,737 | $62.7776 | $109K |
Footnotes (3)
- F1. Stock sale was to cover the option exercise price and taxes.
- F2. The stock option becomes exercisable in four equal annual installments.
- F3. Not applicable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Non-Qualified Stock Option financial
exercise price financial
open market or private transaction financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Exponent (EXPO) report for CEO Catherine Corrigan?
What options did Exponent (EXPO)'s CEO exercise on July 15, 2026?
Were Catherine Corrigan’s Exponent (EXPO) trades made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.